Evidence map›Paper›PMID 35624719›Full record

ArticleAntioxidants (Basel, Switzerland)2022

OPDAylation of Thiols of the Redox Regulatory Network In Vitro.

Madita Knieper, Lara Vogelsang, Tim Guntelmann, Jens Sproß, Harald Gröger, Andrea Viehhauser, Karl-Josef Dietz

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Madita KnieperBiochemistry and Physiology of Plants, Faculty of Biology, Bielefeld University, 33615 Bielefeld, Germany.
Lara VogelsangBiochemistry and Physiology of Plants, Faculty of Biology, Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0002-5310-1708
Tim GuntelmannIndustrial Organic Chemistry and Biotechnology, Faculty of Chemistry, Bielefeld University, 33615 Bielefeld, Germany.
Jens SproßIndustrial Organic Chemistry and Biotechnology, Faculty of Chemistry, Bielefeld University, 33615 Bielefeld, Germany.
Harald GrögerIndustrial Organic Chemistry and Biotechnology, Faculty of Chemistry, Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0001-8582-2107
Andrea ViehhauserBiochemistry and Physiology of Plants, Faculty of Biology, Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0002-0270-0292
Karl-Josef DietzBiochemistry and Physiology of Plants, Faculty of Biology, Bielefeld University, 33615 Bielefeld, Germany.ORCID 0000-0003-0311-2182
Bielefeld University · DE

Funding

Deutsche Forschungsgemeinschaft DI346/22-1 and 23-1
6 · The paper itself

Abstract

cis-(+)-12-Oxophytodienoic acid (OPDA) is a reactive oxylipin produced by catalytic oxygenation of polyunsaturated α-linolenic acid (18:3 (ω - 3)) in the chloroplast. Apart from its function as precursor for jasmonic acid synthesis, OPDA serves as a signaling molecule and regulator on its own, namely by tuning enzyme activities and altering expression of OPDA-responsive genes. A possible reaction mechanism is the covalent binding of OPDA to thiols via the addition to the C=C double bond of its α,β-unsaturated carbonyl group in the cyclopentenone ring. The reactivity allows for covalent modification of accessible cysteinyl thiols in proteins. This work investigated the reaction of OPDA with selected chloroplast and cytosolic thioredoxins (TRX) and glutaredoxins (GRX) of

Indexed as

Arabidopsis thalianaoxylipinposttranslational modificationthiolthioredoxin

Identifiers

PMID35624719
PMCPMC9137622
OpenAlexW4282930755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.